Delisted
Stopped trading. Fund positions aren't valued until we confirm what happened.
64
NEUBASE THERAPEUTICS INC
64132K102·Common Stock
64132K102 (NEUBASE THERAPEUTICS INC) is held by 0 institutional investors as of Q2 2023.
0
Holders
$0
Total Value
0%
Consensus
13F: Insider & Congress: Updated regularly
Top Holders
Checking access…
| Action | ||||||
|---|---|---|---|---|---|---|
Exited | 0(-100.0%) | $32,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $0 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $8,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $231,250 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $504,500 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $3,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $3,564 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $83 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $5,550 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $94,290 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $79 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $2,612 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $10,161 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $689 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $43,285 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $5,497 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1,912 | 0.0% | — | 0 |
Continue exploring
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer